The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Ryali Sriram since 2019.
This trader's CIK number is 1762893.
At the time of last reporting, Ryali Sriram was the Chief Financial Officer of Caribou Biosciences, Inc.. (stock ticker symbol CRBU).
Also see all insider trading activities at Caribou Biosciences, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | EIGR | 0 | $0 | 2,266 | $12,682 | 0 | $0 |
| 2019 | EIGR | 1,250 | $13,852 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | CRBU | 17,360 | $24,651 | 0 | $0 | 0 | $0 |
1. Eiger Biopharmaceuticals, Inc. (EIGR)
2. Caribou Biosciences, Inc. (CRBU)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-03-14 | EIGR | Sale | 2,266 | 5.60 | 12,682 |
| 2019-04-22 | EIGR | Buy | 1,250 | 11.08 | 13,852 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-01-29 | CRBU | Buy | 17,360 | 1.42 | 24,651 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ryali Sriram (Chief Financial Officer of Caribou Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.